C179H194F8N38O21 — CID 157274240
2-(1-cyanocyclopropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;6-(2-cyanopropan-2-yl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridazine-4-carboxamide;2-cyclopropyl-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-2-fluoro-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide (PubChem CID 157274240) has the molecular formula C179H194F8N38O21 and a molecular weight of 3365.75 g/mol. Its IUPAC name is 2-(1-cyanocyclopropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;6-(2-cyanopropan-2-yl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridazine-4-carboxamide;2-cyclopropyl-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-2-fluoro-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide.
| Compound Name | 2-(1-cyanocyclopropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;6-(2-cyanopropan-2-yl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridazine-4-carboxamide;2-cyclopropyl-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-2-fluoro-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
|---|---|
| PubChem CID | 157274240 |
| Molecular Formula | C179H194F8N38O21 |
| Molecular Weight | 3365.75 g/mol |
| Exact Mass | 3363.52 |
| IUPAC Name | 2-(1-cyanocyclopropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;6-(2-cyanopropan-2-yl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridazine-4-carboxamide;2-cyclopropyl-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-2-fluoro-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(2-fluoropropan-2-yl)pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| SMILES | CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(C)(C)F)c3)c(F)cc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(C)(C)F)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(F)(F)F)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(F)F)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C4(C#N)CC4)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C4CC4)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3cnnc(C(C)(C)C#N)c3)ccc2C)cc1N1CCOCC1 |
| InChI | InChI=1S/C27H28N6O3.C26H29F2N5O3.C26H30FN5O3.C26H29N7O3.C26H29N5O3.C24H24F3N5O3.C24H25F2N5O3/c1-3-36-26-23(33-10-12-35-13-11-33)16-22(31-32-26)21-15-20(5-4-18(21)2)30-25(34)19-6-9-29-24(14-19)27(17-28)7-8-27;1-5-36-25-22(33-8-10-35-11-9-33)15-20(31-32-25)18-14-21(19(27)12-16(18)2)30-24(34)17-6-7-29-23(13-17)26(3,4)28;1-5-35-25-22(32-10-12-34-13-11-32)16-21(30-31-25)20-15-19(7-6-17(20)2)29-24(33)18-8-9-28-23(14-18)26(3,4)27;1-5-36-25-22(33-8-10-35-11-9-33)14-21(30-32-25)20-13-19(7-6-17(20)2)29-24(34)18-12-23(31-28-15-18)26(3,4)16-27;1-3-34-26-24(31-10-12-33-13-11-31)16-23(29-30-26)21-15-20(7-4-17(21)2)28-25(32)19-8-9-27-22(14-19)18-5-6-18;1-3-35-23-20(32-8-10-34-11-9-32)14-19(30-31-23)18-13-17(5-4-15(18)2)29-22(33)16-6-7-28-21(12-16)24(25,26)27;1-3-34-24-21(31-8-10-33-11-9-31)14-19(29-30-24)18-13-17(5-4-15(18)2)28-23(32)16-6-7-27-20(12-16)22(25)26/h4-6,9,14-16H,3,7-8,10-13H2,1-2H3,(H,30,34);6-7,12-15H,5,8-11H2,1-4H3,(H,30,34);6-9,14-16H,5,10-13H2,1-4H3,(H,29,33);6-7,12-15H,5,8-11H2,1-4H3,(H,29,34);4,7-9,14-16,18H,3,5-6,10-13H2,1-2H3,(H,28,32);4-7,12-14H,3,8-11H2,1-2H3,(H,29,33);4-7,12-14,22H,3,8-11H2,1-2H3,(H,28,32) |
| InChIKey | AYXCCQBCGBNOHL-UHFFFAOYSA-N |
| XLogP | 29.48 |
| TPSA | 686.76 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 246 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3365.75 |
| LogP ≤ 5 | 29.48 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 52 |